LL-37 and VIP Interaction
LL-37 and VIP have a compatible interaction with 90% confidence. Both have anti-inflammatory properties. These compounds primarily affect different organ systems.
Compound Profiles
LL-37
Human Cathelicidin | Antimicrobial Peptide
Provides direct antimicrobial activity through membrane disruption, promotes wound healing by enhancing keratinocyte migration and angiogenesis, and modulates immune responses without systemic exposure when used topically..
View full profileVIP
Vasoactive Intestinal Peptide | Neuropeptide
VIP binds to VPAC1 and VPAC2 G protein-coupled receptors, activating adenylyl cyclase and increasing intracellular cAMP and PKA activity. This triggers phosphorylation of CREB and other transcription factors.
View full profileCombined Organ Load
Frequently Asked Questions
Can I take LL-37 with VIP?
Yes, LL-37 and VIP can generally be taken together. Both have anti-inflammatory properties.
Is LL-37 and VIP safe together?
Based on documented research, this combination is considered compatible. No critical safety flags identified for this pair.
What are the interactions between LL-37 and VIP?
Both have anti-inflammatory properties. This assessment has 90% confidence and is based on documented research data.
How should I time LL-37 and VIP?
LL-37 has a half-life of Short (rapid proteolytic degradation) and VIP has a half-life of 1-2 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.